We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$119M
Cap. Flow
+$156M
Cap. Flow %
6.28%
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.89%
2 Financials 8.07%
3 Healthcare 5.89%
4 Consumer Discretionary 5.37%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEA
2601
DELISTED
China Eastern Airlines
CEA
$3K ﹤0.01%
158
+71
+82% +$1.36K
FEO
2602
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$3K ﹤0.01%
203
AERI
2603
DELISTED
Aerie Pharmaceuticals
AERI
$3K ﹤0.01%
+302
New +$4.42K
CCXI
2604
DELISTED
ChemoCentryx, Inc.
CCXI
$3K ﹤0.01%
+186
New +$2.9K
TPTX
2605
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3K ﹤0.01%
+48
New +$3.42K
KL
2606
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$3K ﹤0.01%
78
-19
-20% -$772
SBNY
2607
DELISTED
Signature Bank
SBNY
$3K ﹤0.01%
11
+6
+120% +$1.51K
AAON icon
2608
Aaon
AAON
$7.77B
$2K ﹤0.01%
41
+15
+58% +$651
ABUS icon
2609
Arbutus Biopharma
ABUS
$915M
$2K ﹤0.01%
550
ACIW icon
2610
ACI Worldwide
ACIW
$5.42B
$2K ﹤0.01%
78
+49
+169% +$1.63K
ACTG icon
2611
Acacia Research
ACTG
$470M
$2K ﹤0.01%
+315
New +$1.93K
ADEA icon
2612
Adeia
ADEA
$3.11B
$2K ﹤0.01%
431
+140
+48% +$754
ADT icon
2613
ADT
ADT
$5.58B
$2K ﹤0.01%
302
-17
-5% -$157
ADVM
2614
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
100
-2,411
-96% -$61.5K
AGEN
2615
Agenus
AGEN
$290M
$2K ﹤0.01%
21
AGIO icon
2616
Agios Pharmaceuticals
AGIO
$1.93B
$2K ﹤0.01%
53
-18
-25% -$870
AGM icon
2617
Federal Agricultural Mortgage
AGM
$2.56B
$2K ﹤0.01%
16
+11
+220% +$1.09K
AHRT
2618
AH Realty Trust
AHRT
$517M
$2K ﹤0.01%
+155
New +$2.05K
AIR icon
2619
AAR Corp
AIR
$5.76B
$2K ﹤0.01%
65
ALGM icon
2620
Allegro MicroSystems
ALGM
$8.16B
$2K ﹤0.01%
+70
New +$2.06K
ALKS icon
2621
Alkermes
ALKS
$8.25B
$2K ﹤0.01%
81
+67
+479% +$1.89K
ALX
2622
Alexander's
ALX
$1.41B
$2K ﹤0.01%
+8
New +$2.14K
AMPH icon
2623
Amphastar Pharmaceuticals
AMPH
$916M
$2K ﹤0.01%
+109
New +$2.13K
AMWD
2624
DELISTED
American Woodmark
AMWD
$2K ﹤0.01%
26
APLS
2625
DELISTED
Apellis Pharmaceuticals
APLS
$2K ﹤0.01%
59

Similar funds

Parallel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $156M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.

  • Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
  • Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
  • Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
  • Parallel Advisors opened 363 new positions and closed 191 in Q3 2021.
  • Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.